BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 26341752)

  • 21. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adjuvant treatments in breast cancer: interest of completion of axillary dissection in case of micrometastases or isolated tumor cells in sentinel lymph node].
    Schmitt C; Bouteille C; Faure C; Mignotte H; Tredan O; Bachelot T; Guastalla JP; Arnaud A; Treilleux I; Carrabin N
    Bull Cancer; 2012 Apr; 99(4):463-9. PubMed ID: 22266799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Avoidance of axillary lymph node dissection in breast cancer patients with metastatic sentinel node - a pilot study].
    Černá M; Zedníková I; Ňaršanská A; Svoboda T; Hes O; Záhlava J; Hlaváčková M
    Rozhl Chir; 2015 Mar; 94(3):117-25. PubMed ID: 25754480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of non-sentinel node metastases in patients with symptomatic cancers compared to screen-detected breast cancers.
    Tvedskov TF; Jensen MB; Balslev E; Garne JP; Vejborg I; Christiansen P; Ejlertsen B; Kroman N
    Acta Oncol; 2016; 55(4):455-9. PubMed ID: 26452696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.
    Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of sentinel lymph node biopsy in breast cancer, in and out of vogue?
    Jaffer S; Bleiweiss IJ
    Adv Anat Pathol; 2014 Nov; 21(6):433-42. PubMed ID: 25299312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?
    Joyce DP; Solon JG; Prichard RS; Power C; Hill AD
    Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up.
    Kim HJ; Son BH; Lim WS; Seo JY; Koh BS; Lee JW; Gong GY; Ahn SH
    Ann Surg Oncol; 2010 Aug; 17(8):2126-31. PubMed ID: 20162458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradigm shift in axilla surgery for breast cancer patients treated with sentinel node biopsy.
    Imoto S; Isaka H; Sakemura N; Ito H; Imi K; Miyamoto K
    Breast Cancer; 2012 Apr; 19(2):104-9. PubMed ID: 22038672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Hélène C; Belichard C; Uzan S; Hudry D; Azuar P; Villet R; Penault Llorca F; Tunon de Lara C; Goncalves A; Esterni B;
    Breast; 2014 Oct; 23(5):561-6. PubMed ID: 24874284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axillary node staging for microinvasive breast cancer: is it justified?
    Lyons JM; Stempel M; Van Zee KJ; Cody HS
    Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
    van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
    Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of micrometastases and isolated tumor cells in the sentinel node at early stage breast cancer].
    Cordero García JM; Palomar Muñoz A; Delgado Portela M; García Vicente AM; Pilkington Woll JP; Poblete García VM; Bellón Guardia ME; Pardo García R; Rabadán Ruiz L; Soriano Castrejón A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):78-82. PubMed ID: 21658817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel node biopsy in breast cancer: five years experience from Denmark.
    Christiansen P; Friis E; Balslev E; Jensen D; Møller S;
    Acta Oncol; 2008; 47(4):561-8. PubMed ID: 18465323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.